v3.25.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Income Statement [Abstract] | ||||
| Revenue | $ 58,351 | |||
| Cost of goods sold | 239,040 | 1,074,896 | 239,040 | 2,258,103 |
| Gross loss | (239,040) | (1,074,896) | (239,040) | (2,199,752) |
| Operating expenses: | ||||
| Research and development | 349,951 | 622,567 | 657,681 | 1,382,984 |
| Sales and marketing | 285,035 | 553,390 | ||
| General and administrative | 1,199,323 | 1,977,358 | 2,865,145 | 5,039,684 |
| Total operating expenses | 1,549,274 | 2,884,960 | 3,522,826 | 6,976,058 |
| Loss from operations | (1,788,314) | (3,959,856) | (3,761,866) | (9,175,810) |
| Other income (expense): | ||||
| Interest income | 7,961 | 140,567 | 34,201 | 293,865 |
| Change in fair value - warrant liability | (13,254,700) | 7,937,500 | (12,174,100) | 9,010,300 |
| Change in fair value - derivative liability | 1,130,000 | 2,618,000 | 2,661,000 | 2,627,000 |
| Unrealized gain (loss) on marketable securities | (7,457) | 301,921 | (79,164) | 266,902 |
| Realized gain on marketable securities | 94,492 | 74,998 | 305,554 | 452,121 |
| Consent and waiver fee – Series H-7 | (350,000) | (350,000) | ||
| Other income (expense), net | 25,000 | (198,510) | 66,368 | (198,510) |
| Total other income (expense), net | (12,354,704) | 10,874,476 | (9,536,141) | 12,451,678 |
| Net income (loss) prior to provision for income taxes | (14,143,018) | 6,914,620 | (13,298,007) | 3,275,868 |
| Provision for income taxes | ||||
| Net income (loss) | (14,143,018) | 6,914,620 | (13,298,007) | 3,275,868 |
| Dividends earned on Series H-7 convertible preferred stock | (870,461) | (546,648) | (1,704,194) | (998,734) |
| Accretion of discounts to redemption value of Series H-7 convertible preferred stock | (1,562,047) | (1,999,136) | (3,248,901) | (5,094,609) |
| Net income (loss) attributable to common stockholders | $ (16,575,526) | $ 4,368,836 | $ (18,251,102) | $ (2,817,475) |
| Net income (loss) per share basic | $ (29.87) | $ 12.45 | $ (33.52) | $ (8.55) |
| Net income (loss) per share diluted | $ (29.87) | $ 2.17 | $ (33.52) | $ (8.55) |
| Basic weighted average Common Stock outstanding | 554,989 | 350,983 | 544,474 | 329,422 |
| Diluted weighted average Common Stock outstanding | 554,989 | 1,039,922 | 544,474 | 329,422 |
| X | ||||||||||
- Definition Consent and waiver fee. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as operating. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of realized gain (loss) on investment in marketable security. No definition available.
|
| X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment in marketable security. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|